Bictegravir/Emtricitabine/Tenofovir Alafenamide in Pregnant Women Infected with HIV-1: Real-Life Use
AIDS Research and Human Retroviruses · 2026
DOI: 10.1177/08892229251398861 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2026. Verfasst von Antoine Bachelard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris.Nord, site Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, Hôpitaux Universitaires Pari…. Hauptthemen laut MEDLINE: HIV Infections, Emtricitabine, Pregnancy Complications, Infectious, Anti-HIV Agents. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Bictegravir/Emtricitabine/Tenofovir alafenamide (BIC/FTC/TAF) is a convenient, well-tolerated, once-daily, and single-tablet regimen. There are few data on its use during pregnancy. The primary objective was to evaluate the efficacy of BIC/FTC/TAF at delivery, defined as a plasma viral load
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Assistance Publique-Hôpitaux de Paris.Nord, site Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France.
- Assistance Publique-Hôpitaux de Paris.Nord, site Bichat-Claude Bernard, Service de Virologie, Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France.
- INSERM UMRS1137 IAME, Université Paris Cité, Paris, France.
- Assistance Publique-Hôpitaux de Paris.Nord, site Bichat-Claude Bernard, Service de gynecologie obstretrique, Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France.
- Assistance Publique-Hôpitaux de Paris.Nord, site Bichat-Claude Bernard, Service de neonatalogie, Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France.
- Assistance Publique-Hôpitaux de Paris.Nord, site Bichat-Claude Bernard, Service de Pharmacologie, Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France.
ORCID-Profile: Antoine Bachelard
Zitieren
APA
Bachelard, A., Julia, Z., Damond, F., Barral, T., Pauphilet, V., Nabil, M., Allal, L., Wakim, Y., Lariven, S., Sinna, A., Ferré, V. M., Peytavin, G., & Ghosn, J. (2026). Bictegravir/Emtricitabine/Tenofovir Alafenamide in Pregnant Women Infected with HIV-1: Real-Life Use. AIDS Research and Human Retroviruses. https://doi.org/10.1177/08892229251398861
Vancouver
Bachelard A, Julia Z, Damond F, Barral T, Pauphilet V, Nabil M, et al. Bictegravir/Emtricitabine/Tenofovir Alafenamide in Pregnant Women Infected with HIV-1: Real-Life Use. AIDS Research and Human Retroviruses. 2026. doi:10.1177/08892229251398861
BibTeX
@article{Bachelard2026,
author = {Bachelard, Antoine and Julia, Zélie and Damond, Florence and Barral, Tiphaine and Pauphilet, Victoire and Nabil, Malika and Allal, Lahcene and Wakim, Yara and Lariven, Sylvie and Sinna, Aurélie and Ferré, Valentine-Marie and Peytavin, Gilles and Ghosn, Jade},
title = {Bictegravir/Emtricitabine/Tenofovir Alafenamide in Pregnant Women Infected with HIV-1: Real-Life Use},
journal = {AIDS Research and Human Retroviruses},
year = {2026},
doi = {10.1177/08892229251398861}
}
EUVIMED